Search Results - "Cotte, E."

Refine Results
  1. 1

    Intraperitoneal chemotherapy in advanced gastric cancer. Meta-analysis of randomized trials by Coccolini, F, Cotte, E, Glehen, O, Lotti, M, Poiasina, E, Catena, F, Yonemura, Y, Ansaloni, L

    Published in European journal of surgical oncology (01-01-2014)
    “…Abstract Introduction An important component of treatment failure in gastric cancer (GC) is cancer dissemination within the peritoneal cavity and nodal…”
    Get full text
    Journal Article
  2. 2

    Adherence to monthly and weekly oral bisphosphonates in women with osteoporosis by Cotté, F.-E, Fardellone, P, Mercier, F, Gaudin, A.-F, Roux, C

    Published in Osteoporosis international (01-01-2010)
    “…Summary This primary care database survey evaluated whether osteoporotic women treated with bisphosphonates were more adherent to monthly than to weekly…”
    Get full text
    Journal Article
  3. 3

    Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Persistent and Recurrent Advanced Ovarian Carcinoma: A Multicenter, Prospective Study of 246 Patients by Bakrin, N., Cotte, E., Golfier, F., Gilly, F. N., Freyer, G., Helm, W., Glehen, O., Bereder, J. M.

    Published in Annals of surgical oncology (01-12-2012)
    “…Background Epithelial ovarian carcinoma is the main cause of death from gynaecological cancers in the western world. The initial response rate to the frontline…”
    Get full text
    Journal Article
  4. 4

    Intolerance to early oral feeding in enhanced recovery after colorectal surgery: an early red flag? by Slim, K., Reymond, T., Joris, J., Paul, S., Pereira, B., Cotte, E.

    Published in Colorectal disease (01-01-2020)
    “…Aim Enhanced recovery programmes (ERPs) involve early postoperative oral feeding. The aim of this study was to test the hypothesis that intolerance to early…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7

    Postoperative outcomes of laparoscopic vs open cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy for treatment of peritoneal surface malignancies by Passot, G, Bakrin, N, Isaac, S, Decullier, E, Gilly, F.N, Glehen, O, Cotte, E

    Published in European journal of surgical oncology (01-08-2014)
    “…Abstract Background Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) are considered the only curative treatment for many…”
    Get full text
    Journal Article
  8. 8

    Laparoscopic Colonic Resection Without Urinary Drainage: Is It “Feasible”? by Alyami, M., Lundberg, P., Passot, G., Glehen, Olivier, Cotte, E.

    Published in Journal of gastrointestinal surgery (01-07-2016)
    “…Background Urinary retention following colorectal surgery is a known and costly morbidity. Increasing effort is being made to streamline patient recovery…”
    Get full text
    Journal Article
  9. 9

    Impact of early biochemical diagnosis of anastomotic leakage after rectal cancer surgery: long-term results from GRECCAR 5 trial by Denost, Q, Rouanet, P, Faucheron, J-L, Panis, Y, Meunier, B, Cotte, E, Meurette, G, Portier, G, Sabbagh, C, Loriau, J, Benoist, S, Piessen, G, Sielezneff, I, Lelong, B, Mauvais, F, Romain, B, Barussaud, M-L, Capdepont, M, Laurent, C, Rullier, E

    Published in British journal of surgery (01-06-2021)
    “…A raised C-reactive protein level should be used to prompt early detection of anastomotic leakage before development of clinical symptoms. Early biochemical…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Management of perianal fistulas in Crohn’s disease: a 2021 update of the French National Society of Coloproctology consensus by Bouchard, D., Pigot, F., de Parades, V., Staumont, G., Abramowitz, L., Siproudhis, L.

    Published in Techniques in coloproctology (01-10-2022)
    “…Background Since our last publication of algorithms for the management of perianal fistulas in patients with Crohn’s disease, researchers have proposed a treat…”
    Get full text
    Journal Article
  12. 12

    Learning curve for robotic-assisted total mesorectal excision: a multicentre, prospective study by Arquillière, J, Dubois, A, Rullier, E, Rouanet, P, Denost, Q, Celerier, B, Pezet, D, Passot, G, Aboukassem, A, Colombo, P E, Mourregot, A, Carrere, S, Vaudoyer, D, Gourgou, S, Gauthier, L, Cotte, E

    Published in Colorectal disease (01-09-2023)
    “…Robotic-assisted surgery (RAS) is becoming increasingly important in colorectal surgery. Recognition of the short, safe learning curve (LC) could potentially…”
    Get full text
    Journal Article
  13. 13

    Intraperitoneal-Free Cancer Cells Represent a Major Prognostic Factor in Colorectal Peritoneal Carcinomatosis by Trilling, B, Cotte, E, Vaudoyer, D, Isaac, S, Piaton, E, Maurice, C, Glehen, O, Passot, G

    Published in Diseases of the colon & rectum (01-07-2016)
    “…BACKGROUND:Intraperitoneal-free cancer cells are considered as an important prognostic tool in gastric and ovarian cancer. However, their significance in…”
    Get full text
    Journal Article
  14. 14

    Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal cancer: a 13 years-retrospective monocentric study by Livin, M, Leonard, D, Bachmann, R, Remue, C, Barbois, S, Cotte, E, Van Den Eynde, M, De Cuyper, A, Sinapi, I, Van Maanen, A, Kartheuser, A

    Published in Acta gastro-enterologica belgica (01-10-2022)
    “…Over the last 20 years, cytoreductive surgery (CRS) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) has progressively become a therapeutic…”
    Get more information
    Journal Article
  15. 15

    Malignant Peritoneal Mesothelioma Treated by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Is GLUT1 Expression a Major Prognostic Factor? A Preliminary Study by Hommell-Fontaine, J., Isaac, S., Passot, G., Decullier, E., Traverse-Glehen, A., Cotte, E., You, B., Mohamed, F., Gilly, F. N., Glehen, O., Berger, F.

    Published in Annals of surgical oncology (01-11-2013)
    “…Purpose Diffuse malignant peritoneal mesothelioma (DMPM) is a rare primary peritoneal malignancy. Its prognosis has been improved by an aggressive locoregional…”
    Get full text
    Journal Article
  16. 16

    Quality of life after cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy: A prospective study of 216 patients by Passot, G, Bakrin, N, Roux, A.S, Vaudoyer, D, Gilly, F.-N, Glehen, O, Cotte, E

    Published in European journal of surgical oncology (01-05-2014)
    “…Abstract Introduction Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) have demonstrated promising results in the treatment of…”
    Get full text
    Journal Article
  17. 17

    Validation of the adherence evaluation of osteoporosis treatment (ADEOS) questionnaire for osteoporotic post-menopausal women by Breuil, V., Cortet, B., Cotté, F.-E., Arnould, B., Dias-Barbosa, C., Gaudin, A.-F., Regnault, A., Roborel de Climens, A., Legrand, E.

    Published in Osteoporosis international (01-02-2012)
    “…Summary We developed and validated a specific 12-item questionnaire to evaluate adherence to oral antiresorptive medication by post-menopausal osteoporotic…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Lack of prognostic significance of conventional peritoneal cytology in colorectal and gastric cancers: Results of EVOCAPE 2 multicentre prospective study by Cotte, E, Peyrat, P, Piaton, E, Chapuis, F, Rivoire, M, Glehen, O, Arvieux, C, Mabrut, J.-Y, Chipponi, J, Gilly, F.-N

    Published in European journal of surgical oncology (01-07-2013)
    “…Abstract Aim In digestive cancers, the prognostic significance of intraperitoneal free cancer cells remains unclear (IPCC). The main objective of this study…”
    Get full text
    Journal Article
  20. 20